|
gptkbp:instanceOf
|
vaccine
|
|
gptkbp:administeredBy
|
percutaneous scarification
|
|
gptkbp:approvalYear
|
2007
|
|
gptkbp:approvedBy
|
gptkb:U.S._Food_and_Drug_Administration
|
|
gptkbp:ATCCode
|
gptkb:J07BX
|
|
gptkbp:contains
|
live vaccinia virus
|
|
gptkbp:contraindication
|
gptkb:eczema
pregnancy
HIV infection
immunodeficiency
|
|
gptkbp:countryOfOperation
|
gptkb:United_States
|
|
gptkbp:developedBy
|
gptkb:Acambis
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
ACAM2000
|
|
gptkbp:indication
|
gptkb:military
biodefense
laboratory workers exposed to orthopoxviruses
|
|
gptkbp:legalStatus
|
Rx-only (US)
|
|
gptkbp:marketedAs
|
gptkb:Emergent_BioSolutions
|
|
gptkbp:pregnancyCategory
|
contraindicated
|
|
gptkbp:prescriptionStatus
|
prescription only
|
|
gptkbp:regimen
|
single dose
|
|
gptkbp:relatedTo
|
gptkb:JYNNEOS
gptkb:Dryvax
|
|
gptkbp:replacedBy
|
gptkb:Dryvax
|
|
gptkbp:routeOfAdministration
|
intradermal
|
|
gptkbp:sideEffect
|
fever
pericarditis
rash
lymphadenopathy
myocarditis
|
|
gptkbp:storage
|
2-8°C
|
|
gptkbp:type
|
live attenuated vaccine
|
|
gptkbp:usedFor
|
prevention of monkeypox
prevention of smallpox
|
|
gptkbp:website
|
https://www.acambis.com/acam2000
|
|
gptkbp:WHOStatus
|
not on WHO Essential Medicines List
|
|
gptkbp:bfsParent
|
gptkb:Vaccinia_virus
gptkb:2022–2023_global_outbreak
gptkb:vaccinia
|
|
gptkbp:bfsLayer
|
6
|